Alexander P. OttAssociateMcDermott Will & Emery Websitewww.mwe.comBlogwww.mwe.com/insightsConnectEmail202-756-8496 Professional Biography Alexander P. Ott is an associate in the law firm of McDermott Will & Emery LLP and is based in the Firm’s Washington, D.C., office. Alex focuses his practice on intellectual property litigation. More Legal and Business Bylines From Alexander P. Ott Possible, Probable Features of Prior Art Do Not Establish Inherency - (Posted On Friday, May 27, 2016) LED Patent Rendered Obvious by Earlier LED Breakthrough - (Posted On Friday, April 29, 2016) Inconsistent and Confusing Specification Language Does Not Support Broad Claim Construction - (Posted On Wednesday, March 30, 2016) Previously Denied Section 101 Defense Rendered Meritorious by the Supreme Court’s Alice Decision - (Posted On Thursday, February 25, 2016) Motion to Amend in IPR Must Establish Patentability Over Prior Art from Original Prosecution - (Posted On Friday, January 29, 2016) PTAB Grants Patent Owner Request for Surreply to Defend Reduction to Practice Claim - (Posted On Tuesday, December 22, 2015) PTAB Finds Claims to Be Directed to Covered Business Method, but Denies Institution Anyway - (Posted On Tuesday, December 01, 2015) “Mechanism” Claim Term Found to Be an Indefinite Means-Plus-Function Element in Media Rights Techs. v. Capital One Financial Corp. - (Posted On Monday, November 02, 2015) Claims Obvious Despite Contrary Jury Verdict - (Posted On Wednesday, September 30, 2015) Steps that Simply Map Out an Application on a Computer Do Not Confer Patent Eligibility Intellectual Ventures I LLC v. Capital One Financial - (Posted On Wednesday, August 26, 2015) Pagination Previous page ‹ Previous Page 5 Next page Next › Current Legal Analysis DOE Releases SAF Grand Challenge Roadmap Implementation Framework by: Lynn L. Bergeson , Carla N. Hutton California DFPI Poised to Fill Potential Regulatory Gap Amid Anticipated CFPB Leadership Shift by: A.J. S. Dhaliwal , Mehul N. Madia FDA Extends Comment Deadline for Proposed Post-Market Assessment Approach by: Food and Drug Law at Keller and Heckman Understanding French Export and Re-Export Prohibitions: Ministry of Armed Forces Releases FAQ on Non Re-Exportation Certificates by: Sabine Naugès , Michal Chajdukowski New CFPB Larger Participant Rule Boosts Oversight of Major Digital Payment Providers by: A.J. S. Dhaliwal , Mehul N. Madia California Poised to Fill Potential Regulatory Gap Amid Anticipated CFPB Leadership Shift by: A.J. S. Dhaliwal , Mehul N. Madia Upcoming Events Dec 10 2024 Legal AI Week 2024 Nov 25 2024 2024 Election: Impact on the Health Care Legal and Policy Landscape Webinar Dec 4 2024 TSCA 30/30 - December 4, 2024 Dec 4 2024 GLP-1 Drugs: What's Next after FDA's Resolution of Drug Shortages Dec 4 2024 REACH 30/30 - 04 December 2024 Dec 5 2024 Home Care Industry Update Dec 5 2024 Annual Review: Non-compete and Trade Secret Protection for Employers Dec 11 2024 2025 Annual Reporting & Proxy Season Update Print
